Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Zykadia 2015 U.S Physician Engagement Report

ReportBuyer
Posted on: 19 Oct 16

PR Newswire

LONDON, Oct. 18, 2016


LONDON, Oct. 18, 2016 /PRNewswire/ -- Summary

Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively engage with physicians throughout the product lifecycle.

In order to address this critical issue, MDDetails leverages Sunshine Act disclosures (i.e., CMS Open Payments) to provide product and physician level promotional benchmarking across more than 500 marketed U.S. products. Each physician engagement report enables insight into personal promotional activity (e.g., education and detailing) for a specific product and its relevant peer set. Detailed analyses around coverage, specialty mix, rep access, and detailing frequency are provided. Furthermore, KOL engagement and ongoing market development activity (e.g., research, consulting, and speaking) is also discussed.

Report Scope

- A comprehensive assessment of Novartis physician engagement activity for Zykadia in 2015 (Over 4,700 paid interactions across 2,500 physicians)
- Promotional benchmarking (e.g. total reach and specialty mix) for Zykadia and 11 peer product(s) in key market(s), including: Non-Small Cell Lung Cancer
- Longitudinal view of Zykadia interaction frequency and mix (e.g. meal, speaking, education, consulting, and research)
- In-depth analysis of Zykadia sales rep access within key specialties, including: Hematology/Oncology, Medical Oncology, Internal Medicine, and Radiation Oncology
- Ranked lists of most engaged physicians, opinion leaders, and clinical researchers for Zykadia in 2015 (Up to the top 30 in each category)

Reasons to buy

- Understand the full breadth of market development and promotional activity for Zykadia and its competitors in 2015
- Gain insight into marketing mix, promotional spend and longitudinal trends
- Benchmark prescriber access and detailing frequency within key specialties and geographies
- Obtain top Zykadia sales targets and opinion leaders in 2015

Download the full report: https://www.reportbuyer.com/product/4070833/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zykadia-2015-us-physician-engagement-report-300347237.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 19/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.